Company news

Mainz Biomed & Dante Labs Announce Partnership for the Commercialization of ColoAlert in Europe and the United Arab Emirates (UAE)

Mainz Biomed e Dante Labs annunciano una partne...

Dante Labs è un leader globale nella genomica e nella medicina di precisioneMainz è focalizzata esclusivamente sullo sviluppo della diagnostica di nuova generazione per la diagnosi precoce del cancro  ...

Mainz Biomed e Dante Labs annunciano una partne...

Dante Labs è un leader globale nella genomica e nella medicina di precisioneMainz è focalizzata esclusivamente sullo sviluppo della diagnostica di nuova generazione per la diagnosi precoce del cancro  ...

Dante Labs selected to provide genetic testing for Abu Dhabi Stem Cells Center, jointly developing mRNA cancer vaccines

Dante Labs selected to provide genetic testing ...

  NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, is pleased to announce the company has been selected as the genetic...

Dante Labs selected to provide genetic testing ...

  NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, is pleased to announce the company has been selected as the genetic...

Dante Labs announces ventures into biosimulation and drug discovery, demonstrating the predictive value of the Dante Platform

Dante Labs announces ventures into biosimulatio...

NEW YORK, April. 11, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomic information and precision medicine, announces new genomic driven biosimulation and significant progress made to its drug discovery program,...

Dante Labs announces ventures into biosimulatio...

NEW YORK, April. 11, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomic information and precision medicine, announces new genomic driven biosimulation and significant progress made to its drug discovery program,...

Dante Labs establishes the first of its Regional Medical Genomics Boards in Europe made of national and multinational world leaders in genomics

Dante Labs establishes the first of its Regiona...

NEW YORK, March. 24, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, announces the establishment of the first of its Medical Genomics Boards, strengthening the Company’s mission and...

Dante Labs establishes the first of its Regiona...

NEW YORK, March. 24, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, announces the establishment of the first of its Medical Genomics Boards, strengthening the Company’s mission and...

Dante Labs unveils Dante Genomics, the Company’s B2B global online marketplace delivering genomic solutions for medical professionals, researchers and pharma

Dante Labs unveils Dante Genomics, the Company’...

– Global wholesale customers now have easy access to advanced, tailored end-to-end genomic services to suit specific needs –   NEW YORK, March. 14, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in...

Dante Labs unveils Dante Genomics, the Company’...

– Global wholesale customers now have easy access to advanced, tailored end-to-end genomic services to suit specific needs –   NEW YORK, March. 14, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in...

Dante Labs announces expansion of its Whole Genome Sequencing test with enhanced and broader offering

Dante Labs announces expansion of its Whole Gen...

NEW YORK, March 3, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, today announced the expansion of its Dante 30X Whole Genome Sequencing Test with personalized...

Dante Labs announces expansion of its Whole Gen...

NEW YORK, March 3, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, today announced the expansion of its Dante 30X Whole Genome Sequencing Test with personalized...